Recently, Zhongshan Hospital affiliated with Fudan University and the Shanghai Institute for Advanced Study jointly released CardioMind, China's first cardiovascular specialty medical AI large model. This innovative technology marks the arrival of a new era of intelligent cardiovascular diagnosis and treatment.

Dubbed the "AI Cardiologist," the model aims to mimic the thinking patterns of top experts to improve the efficiency of cardiovascular disease diagnosis and treatment. Academician Ge Junbo, director of cardiology, stated at the launch that CardioMind is not just about inputting data into AI; it's about teaching AI to think and reason like an expert. By integrating various forms of diagnostic data, the model can achieve intelligent automation throughout the entire process, from medical history collection to auxiliary diagnosis, significantly enhancing the diagnostic and therapeutic capabilities for cardiovascular diseases.

MRI Medical (2)

Image Source Note: Image generated by AI, image licensing provided by Midjourney

The CardioMind development team introduced that the model's knowledge base focuses on cardiovascular diseases, covering multiple sub-specialty areas such as coronary heart disease, arrhythmias, and heart failure. Its biggest highlight is breaking through the limitations of traditional AI models, enabling it to process multi-modal data such as electrocardiograms, ultrasound images, and laboratory tests. This integration allows doctors to obtain more accurate auxiliary diagnoses when dealing with complex cases.

Ge Junbo revealed that Zhongshan Hospital's cardiology department received 820,000 patients last year. With the help of CardioMind, doctors can not only see more patients but also reduce their daily workload. Zhou Jian, president of Zhongshan Hospital, pointed out that with the application of AI technology, medical work will gradually achieve "autopilot," allowing doctors to focus more on research into difficult cases and in-depth communication with patients.

However, the security of medical data and the ethical issues of AI remain challenges for the industry. To address data security, the CardioMind team has established a strict data firewall to ensure the encryption of patient privacy information. Furthermore, the application of AI in medical decision-making requires more comprehensive legal regulations to ensure that doctors' legal liabilities are protected.

Looking ahead, CardioMind will further improve its functions, including personalized treatment decision support, machine learning for disease risk prediction, and surgical planning assisted by image data. It will translate the experience of top experts into replicable "digital diagnostic capabilities," accelerating the dissemination of high-quality medical resources.